Skip to main content
Log in

Risiken ungünstiger Kosmetik und Toxizität nach perkutaner akzelerierter Teilbrustbestrahlung (APBI)

Interimsanalyse der kanadischen RAPID-Studie

Risks of unfavorable cosmetic and toxicity after percutaneous accelerated partial breast irradiation (APBI)

Interim analysis from the Canadian RAPID trial

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Aaronson NK, Bartelink H, Dongen JA van et al (1988) Evaluation of breast conserving therapy: clinical, methodological and psychosocial perspectives. Eur J Surg Oncol 14:133–140

    PubMed  CAS  Google Scholar 

  2. Bentzen SM, Yarnold JR (2010) Reports of unexpected late side effects of accelerated partial breast irradiation–radiobiological considerations. Int J Radiat Oncol Biol Phys 77:969–973

    Article  PubMed  Google Scholar 

  3. Bentzen SM, Ruifrok AC, Thames HD (1996) Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy. Radiother Oncol 38:89–101

    Article  PubMed  CAS  Google Scholar 

  4. Bentzen SM, Saunders MI, Dische S (1999) Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Radiother Oncol 53:219–226

    Article  PubMed  CAS  Google Scholar 

  5. Guttenberger R, Thames HD, Ang KK (1992) Is the experience with CHART compatible with experimental data? A new model of repair kinetics and computer simulations. Radiother Oncol 25:280–286

    Article  PubMed  CAS  Google Scholar 

  6. Hepel JT, Tokita M, MacAusland SG et al (2009) Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 75:1290–1296

    Article  PubMed  Google Scholar 

  7. Jagsi R, Ben-David MA, Moran JM et al (2010) Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 76:71–78

    Article  PubMed  Google Scholar 

  8. Levine MN, Guyatt GH, Gent M et al (1988) Quality of life in stage II breast cancer: an instrument for clinical trials. J Clin Oncol 6:1798–1810

    PubMed  CAS  Google Scholar 

  9. Olivotto IA, Whelan TJ, Parpia S et al (2013) Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol [Epub ahead of print]

  10. Whelan T, MacKenzie R, Julian J et al (2002) Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94:1143–1150

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. M.D. Piroth gibt an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M.D. Piroth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piroth, M. Risiken ungünstiger Kosmetik und Toxizität nach perkutaner akzelerierter Teilbrustbestrahlung (APBI). Strahlenther Onkol 189, 1054–1055 (2013). https://doi.org/10.1007/s00066-013-0447-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-013-0447-6

Navigation